TrialInternational journal of clinical oncology2024

Phase II study of S-1 plus docetaxel as first-line treatment for older patients with advanced gastric cancer (OGSG 0902).

Tomono Kawase et al.PubMed ↗Publisher ↗

No numbers read from the abstract.